Latest Anti-diabetic drug Stories
AUGUSTA, Ga., Feb.
DUBLIN, Ireland, January 26 /PRNewswire-FirstCall/ -- ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of a new electronic solution that will accelerate the adjudication of cardiovascular events in diabetes studies. The evaluation of cardiovascular risk in diabetic trials has been the subject of recent FDA guidance.
A Harvard researcher's discovery in a old German medical journal may provide a new, cost-effective way to help treat diabetes. Steven Shoelson found an 1876 article in the journal that suggested the arthritis drug salsalate may help diabetics control their blood sugar, The Wall Street Journal reported Tuesday. Shoelson and colleagues at the Joslin Diabetes Center have been testing the anti-inflammatory drug in several small studies of type 2 diabetes and found it significantly lowered spikes...
LOS ALTOS, Calif., Jan. 8 /PRNewswire/ -- InteKrin Therapeutics, Inc., will present at the 27th Annual JP Morgan Global Healthcare Conference at 9:00 a.m. Pacific Time on Tuesday, January 13, 2009, to be held at the Westin St. Francis in San Francisco, California.
A small study showed that obesity surgery could reverse diabetes in teens, just as it does in adults.
Twenty-three million Americans suffer from Type 2 diabetes, and the FDA says it will now strictly screen the drugs created to treat the epidemic.
HARRISBURG, Pa., Oct. 31 /PRNewswire-USNewswire/ -- November is American Diabetes Month and acting Secretary of Health Everette James today reminded Pennsylvanians that there are steps they can take to reduce the risk of becoming diabetic.
VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced the weight loss effects of Qnexa in subjects with type 2 diabetes at The Obesity Society Annual Scientific Meeting in Phoenix, Arizona. Dr.
- A poem in which the author retracts something said in an earlier poem.